NVWM LLC’s West Pharmaceutical WST Stock Holding History

NVWM LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$742	Hold	2	–	–	﹤0.01%	674
2026 Q2	$718	Hold	2	–	–	﹤0.01%	643
2026 Q1	$501	Sell	2 -1	-33%	-$249	﹤0.01%	650
2025 Q4	$825	Buy	3 +1	+50%	+$274	﹤0.01%	593
2025 Q3	$525	Hold	2	–	–	﹤0.01%	591
2025 Q2	$438	Buy	+2	New	+$428	﹤0.01%	607
2025 Q1	–	Sell	-4	Closed	-$1.31K	–	706
2024 Q4	$1.31K	Buy	4 +3	+300%	+$944	﹤0.01%	427
2024 Q3	$300	Buy	+1	New	+$306	﹤0.01%	592
2018 Q4	–	Sell	-400	Closed	-$49K	–	385
2018 Q3	$49K	Hold	400	–	–	0.03%	183
2018 Q2	$40K	Hold	400	–	–	0.03%	186
2018 Q1	$34K	Hold	400	–	–	0.02%	204
2017 Q4	$39K	Buy	+400	New	+$39.2K	0.03%	183

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Tran Capital Management San Rafael, California $873M AUM 51.28% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

BZWA

Blue Zone Wealth Advisors Los Angeles, California $636M AUM 19.4% 1-Year Est. Return

NVWM LLC's WST Position: Q3 2026 in Review

NVWM LLC held its West Pharmaceutical (WST) position steady in Q3 2026 at 2 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #674.

NVWM LLC first reported a position in WST in Q4 2017 and has held it in 12 quarters since. The position peaked at $49K in Q3 2018. 117 funds tracked by Wall St. Rank hold WST as of Q3 2026.

NVWM LLC held 2 shares of West Pharmaceutical worth $742 as of Q3 2026.
NVWM LLC left its West Pharmaceutical share count unchanged in Q3 2026.
West Pharmaceutical made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #674 holding.
NVWM LLC first reported a position in West Pharmaceutical in Q4 2017 and has held it in 12 quarters since.
NVWM LLC's West Pharmaceutical position peaked at $49K in Q3 2018.
117 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.